Identification of Risk Factors Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriatic Patients
Kirley Küçük(Centre Hospitalier Universitaire de Liège), Farida Benhadou(Erasmus Hospital), Mathieu Daoud(Université Libre de Bruxelles), Fabienne Willaert(Université Libre de Bruxelles), Christophe Moreno(Genfit (France)), Hassane Nijmi(Université Libre de Bruxelles), Dillon Mintoff(University of Malta)
Cited by 4
Related Papers
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
The interleukin-17 pathway is involved in human alcoholic liver disease # †
|Hepatology|2008|385
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
|Hepatology|2006|237
Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
|Dermatology|2018|227
Invasive aspergillosis in patients with severe alcoholic hepatitis
|Journal of Hepatology|2013|149